Spanish physicians point of view on irritable bowel syndrome (IBS): Results of a Delphi survey;Opinión de los médicos españoles sobre el síndrome de intestino irritable: Resultados de un estudio utilizando el método Delphi

Revista Espanola de Enfermedades Digestivas

Volumn 99, Issue 4, 2007, Pages 210-217

  Almansa, C ^a   Rey, E ^a   Bolanos E ^b   Palma, M ^b   Alvarez Sanchez A ^a   Díaz Rubio, Manuel ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Delphi survey; Irritable bowel syndrome

Indexed keywords

ARTICLE; CLINICAL PRACTICE; COLONOSCOPY; DELPHI STUDY; GENERAL PRACTITIONER; HUMAN; IRRITABLE COLON; MEDICAL PRACTICE; MEDICAL SPECIALIST; NORMAL HUMAN; PATIENT CARE; PHYSICIAN; QUESTIONNAIRE; SPAIN; SYMPTOM; THINKING; FEMALE; GASTROENTEROLOGY; GENERAL PRACTICE; MALE; MIDDLE AGED;

DELPHI TECHNIQUE; FAMILY PRACTICE; FEMALE; GASTROENTEROLOGY; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; QUESTIONNAIRES; SPAIN;

EID: 34548379574     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Mearin F, Badia X, Balboa A, Baro E, Caldwell E, Cucala M, et al. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: Comparisons of Rome II versus previous criteria in a general population. Scand J Gastroenterol 2001; 36: 1155-61.
2. Thompson WG, Heaton KW, Smyth GT, Smyth C. Irritable bowel syndrome in general practice: Prevalence, characteristics, and referral. Gut 2000; 46: 78-82.
3. Badia X, Mearin F, Balboa A, Baro E, Caldwell E, Cucala M, et al. Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria. Pharmacoeconomics 2002; 20: 749-58.
4. Sandler RS, Everhart JE, Donwitz M, Adams E, Cronin K, Goodman C, et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002; 122: 1500-11.
5. Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther 2003; 17: 643-50.
6. Jones J, Boorman J, Cann P, Forbes A, Gomborone J, Heaton K, et al. British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome. Gut 2000; 47 (Supl. II): ii1-ii9.
7. Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE. Rome II: the functional gastrointestinal disorders. Diagnosis, pathophysiology and treatment: a multinational consensus. 2nd ed. McLean, Va: Degnon Associates; 2000.
8. Yawn BP, Lydick E, Locke GR, Wollan PC, Bertran SL, Kurland MJ. Do published guidelines for evaluation of irritable bowel syndrome reflect practice? BMC Gastroenterology 2001, I: II.
9. Verhagen AP, De Vet HC, De Brie RA, Kessels AG, Boers M, Bouter LM, et al. The Delphi list a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 1998, 51: 1235-41.
10. Powell C. The delphi technique: myths and realities. J Adv Nurs 2003; 41: 376-82.
11. Mokkink LB, Terwee CB, Knol DL, Stratford DW, Alonso J, Patrick DL, et al. Protocol of the COSMIN study: Consensus based standards for the selection of health measurement instruments. BMC Med Res Methodol 2006; 24: 2.
12. Almasio PL, Niero M, Anglioli D, Ascione A, Gullini S, Minoli G, et al. Experts' opinions on the role of liver biopsy in HCV infection: a Delphi survey by the Italian Association of Hospital Gastroenterologist (A.I.G.O.). J Hepatol 2005; 43(3): 381-7.
13. AGA Technical Review on Irritable Bowel Syndrome. Gastroenterology 2002; 123: 2108-31.
14. American College of Gastroenterology Functional Gastrointestinal Disorders Task Force. Evidence based position statement on the management of irritable bowel syndrome in North America. AJG 2002; 97: 11(Supl.): S1-S5.
15. Chang L, Lee OY, Naliboff B, Schmulson M, Mayer EA. Sensation of bloating and visible abdominal distension in patients with irritable bowel syndrome. Am J Gastroenterol 2001; 96: 3341-7.
16. Hammer J, Eslick GD, Howell SC, Altiparmak E, Talley NJ. Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia. Gut 2004; 53: 666-72.
17. Gladman LM, Gorard DA. General practitioner and hospital specialist attitudes to functional gastrointestinal disorders: Aliment Pharmacol Ther 2003; 17: 651-4.
18. Lea R, Hopkins V, Hastleton J, Houghton LA, Whorwell PJ. Diagnostic criteria for irritable bowel syndrome: Utility and applicability in clinical practice. Digestion 2004; 70: 210-3.
19. Longstrech GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130: 1480-91.
20. Sanders DS, Carter MJ, Hurlstone DP. Association of adult coeliac disease with irritable bowel syndrome: A case-control study in patients fulfilling the ROME II criteria referred to secondary care. Lancet 2001; 358:1504-8.
21. Owens DM, Nelson DK, Talley NJ. The irritable bowel syndrome: Long term prognosis and the physician patient interaction. Ann Intern Med 1995; 122: 107-12.
22. Izquierdo S, Rey E, Garcia Alonso M, Almansa C, Diaz-Rubio M. Has the identification of rectal hypersensitivity any implication in the clinical outcome of irritable bowel syndrome? Rev Esp Enferm Dig 2005; 97: 223-8.
23. Spiller RC. Problems and challenges in the design of irritable bowel syndrome clinical trials: experience from published trials. Am J Med 1999; 107(5A): 91S-97S.
24. Patel SM, Stason WB, Legedza A, Ock SM, Kaptchuk TJ, Conboy L, et al. The placebo effect in irritable bowel syndrome trials: A meta-analysis. Neurogastroenterol Motil 2005; 17: 332-40.